Objective
"PI 3-kinases (PI3Ks) generate intracellular lipid second messengers in signal transduction and membrane trafficking pathways. PI3Ks are implicated in cancer, inflammation and autoimmunity, and represent attractive drug targets. Mammalian PI3K isoforms are divided into class I, II and III PI3Ks. While the class I PI3Ks have been extensively studied and targeted in drug development, the other PI3Ks, especially the class II PI3Ks, remain poorly investigated.
In this proposal, I aim to uncover the signalling mechanisms and functions of the class II PI3K isoforms, PI3K-C2alpha and PI3K-C2beta, by exploiting cells derived from unique gene-targeted mice generated in the Host Laboratory (unpublished) combined with my expertise in intracellular trafficking and imaging studies. Initial characterisation of these mice indicates that these PI3Ks could be drug targets in their own right in cancer and metabolism, observations that this project now seeks to understand at a molecular and cell level.
By screening responses in cells in which class II PI3K isoforms are genetically inactivated in a ‘drug-like’ fashion, I will assess the coupling of these PI3Ks to distinct receptors and their functional impact, interrogate their downstream signalling pathways by phosphoproteomics and lipidomics, and perform a detailed assessment of their spatio-temporal activity upon activation of cell-surface receptors, in order to elucidate their sites of action and the precise subcellular events they regulate. Class II PI3K effector/complexes will be identified. It is poised to unravel new molecular mechanisms interlinking signalling and trafficking.
I will bring expertise currently not available in the Host Laboratory and deliver a cross-disciplinary approach to uncover the mechanisms of action and functional roles of potential drug targets, to strengthen the Host, and to provide guidance for ongoing and future drug development and open up new avenues for exploitation."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- natural sciences biological sciences biochemistry biomolecules lipids
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2012-IIF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
WC1E 6BT LONDON
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.